Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.
暂无分享,去创建一个
[1] M. Peitsch,et al. The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases , 1997, Journal of leukocyte biology.
[2] C. Mackay,et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. , 1997, Circulation.
[3] P. Dorinsky,et al. Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury. , 1993, Journal of applied physiology.
[4] N. Simonian,et al. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. , 1996, Stroke.
[5] K. Matsushima,et al. Detection of urinary interleukin-8 in glomerular diseases. , 1994, Kidney international.
[6] R. Strieter,et al. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. , 1995, Journal of immunology.
[7] Armen B. Shanafelt,et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.
[8] J. Schröder,et al. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. , 1987, Journal of immunology.
[9] F. Balkwill,et al. The cytokine network. , 1989, Immunology today.
[10] G. Opdenakker,et al. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. , 1993, Biochemical and biophysical research communications.
[11] H. Broxmeyer,et al. Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue , 1996, The Journal of experimental medicine.
[12] H. Mikawa,et al. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells , 1992, The Journal of experimental medicine.
[13] D. Schadendorf,et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.
[14] M. Reale,et al. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. , 1997, Journal of vascular research.
[15] R. Bravo,et al. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. , 1995, Journal of immunology.
[16] J. Hogg. Neutrophil kinetics and lung injury. , 1987, Physiological reviews.
[17] B. Rollins,et al. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[18] B. Rovin,et al. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[19] P. Allavena,et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. , 1995, Journal of immunology.
[20] W. Karpus,et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.
[21] B. Bell,et al. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.
[22] B. Rollins,et al. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. , 1991, Blood.
[23] J. McCord,et al. Superoxide radicals in feline intestinal ischemia. , 1981, Gastroenterology.
[24] David J. Smith,et al. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. , 1990, The American journal of pathology.
[25] J. Hoeffel,et al. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. , 1994, Journal of immunology.
[26] M. Matthay,et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. , 1992, The American review of respiratory disease.
[27] T. Schall,et al. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. , 1995, Biochemistry.
[28] T. Williams,et al. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. , 1995, The Journal of clinical investigation.
[29] W. Wood,et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.
[30] T. Schall,et al. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. , 1994, Journal of immunology.
[31] Paul E. Kennedy,et al. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.
[32] M. Baggiolini,et al. Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. , 1996, Journal of immunology.
[33] N. Mukaida,et al. Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production , 1995, Infection and immunity.
[34] T. Brunner,et al. Monocyte chemotactic protein 1 is a potent activator of human basophils , 1992, The Journal of experimental medicine.
[35] E. Appella,et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Connolly,et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.
[37] M. Baggiolini,et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils , 1990, The Journal of experimental medicine.
[38] K. Matsushima,et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.
[39] M. Lamm,et al. IgA nephropathy: perspectives on pathogenesis and classification. , 1985, Clinical nephrology.
[40] L. Williams,et al. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. , 1997, Journal of immunology.
[41] B. Dewald,et al. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.
[42] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[43] E. Appella,et al. Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.
[44] R. Strieter,et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.
[45] R. Whyte,et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.
[46] C. Valeri,et al. Synergism between leukotriene B4 and thromboxane A2 in mediating acid-aspiration injury. , 1992, Surgery.
[47] K. Matsushima,et al. Inhibition of IL-8-induced W3/25+ (CD4+) T lymphocyte recruitment into subcutaneous tissues of rats by selective depletion of in vivo neutrophils with a monoclonal antibody. , 1991, Journal of immunology.
[48] E. Appella,et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line , 1990, The Journal of experimental medicine.
[49] D. S. Garrett,et al. High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.
[50] B. Rollins,et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. , 1995, Journal of immunology.
[51] Koichiro Nakamura,et al. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. , 1995, The Journal of investigative dermatology.
[52] A. Huber,et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.
[53] McCord Jm. Oxygen-derived radicals: a link between reperfusion injury and inflammation. , 1987 .
[54] K. Matsushima,et al. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1) , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] C. Valeri,et al. A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. , 1992, Surgery.
[56] K. Matsushima,et al. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. , 1993, International immunology.
[57] P. Murphy. The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.
[58] Yun Xing,et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate ( , 1993, The Journal of clinical investigation.
[59] T. Murayama,et al. [Molecular mechanism of interleukin-8 gene expression]. , 1994, Rinsho byori. The Japanese journal of clinical pathology.
[60] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[61] T. Yue,et al. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. , 1995, Stroke.
[62] B. Rollins,et al. Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. , 1994, Journal of immunology.
[63] K. Matsushima,et al. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[64] D. Blanchard,et al. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. , 1990, Journal of immunology.
[65] B. Dewald,et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.
[66] D. Remick,et al. Regulation of interleukin 8 gene expression by oxidant stress. , 1993, The Journal of biological chemistry.
[67] S. Kunkel,et al. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. , 1996, Journal of immunology.
[68] R. Strieter,et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.
[69] R. Koehler,et al. Monoclonal Leukocyte Antibody Does Not Decrease the Injury of Transient Focal Cerebral Ischemia in Cats , 1992, Stroke.
[70] D. Taub,et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.
[71] M. Burdick,et al. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.
[72] R. Korthuis,et al. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. , 1988, The American journal of physiology.
[73] H. Folkesson,et al. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. , 1995, The Journal of clinical investigation.
[74] M. Baggiolini,et al. Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] B. Dewald,et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.
[76] D. Salant,et al. RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.
[77] M. Sloan. Thrombolysis and stroke. Past and future. , 1987, Archives of neurology.
[78] K. Matsushima,et al. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[79] C. Valeri,et al. Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil , 1991, The British journal of surgery.
[80] J. Van Damme,et al. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.
[81] K. Matsushima,et al. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor , 1994, Infection and immunity.
[82] K. Matsushima,et al. Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF. , 1995, International immunology.
[83] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[84] E. Appella,et al. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.
[85] K. Matsushima,et al. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.
[86] E. Bauer,et al. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. , 1993, The Journal of biological chemistry.
[87] Obin,et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. , 1989, Science.
[88] K. Matsushima,et al. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene , 1997, Journal of virology.
[89] The adult respiratory distress syndrome. Definition and prognosis. , 1990, Clinics in chest medicine.
[90] N. Mukaida,et al. Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8 , 1994, Journal of virology.
[91] E. Appella,et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.
[92] S. Davis. Tissue rescue therapy for acute ischaemic stroke , 1995, Journal of Clinical Neuroscience.
[93] L. Koenderman,et al. Modulation and induction of eosinophil chemotaxis by granulocyte- macrophage colony-stimulating factor and interleukin-3 , 1991 .
[94] M. Kaliner,et al. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. , 1989, Immunology letters.
[95] J. Norgauer,et al. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.
[96] L. Ernster. Biochemistry of reoxygenation injury , 1988, Critical care medicine.
[97] M. Raffeld,et al. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. , 1991, The Journal of investigative dermatology.
[98] G. Opdenakker,et al. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family , 1992, The Journal of experimental medicine.
[99] M. Baggiolini,et al. Monocyte chemotactic proteins MCP‐1, MCP‐2, and MCP‐3 are major attractants for human CD4+ and CD8+ T lymphocytes , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[100] D. Danilenko,et al. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.
[101] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.
[102] G. Bulkley,et al. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. , 1987, Surgery.
[103] K. Matsushima,et al. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis , 1994, The Journal of experimental medicine.
[104] B. Sykes,et al. Neutrophil activation by monomeric interleukin-8 , 1994 .
[105] S. Coughlin,et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[106] K. Matsushima,et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. , 1996, Kidney international.
[107] Y. Shiga,et al. Neutrophil as a mediator of ischemic edema formation in the brain , 1991, Neuroscience Letters.
[108] M. Baggiolini,et al. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.
[109] N. Mukaida,et al. Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. , 1995, Journal of immunology.
[110] J. Schifferli,et al. NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. , 1990, Biochemical and biophysical research communications.
[111] T. Standiford,et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. , 1995, Journal of immunology.
[112] J. Schröder,et al. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate , 1989, The Journal of experimental medicine.
[113] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[114] J. Minckler. Pathology of the nervous system , 1968 .
[115] A. Siegbahn,et al. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. , 1996, Thrombosis research.
[116] Cameron Js. Glomerulonephritis: current problems and understanding. , 1982 .
[117] D. Remick,et al. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. , 1992, The Journal of clinical investigation.
[118] M. Yamada,et al. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.
[119] D. Graves,et al. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. , 1992, Journal of immunology.
[120] T L Petty,et al. Acute respiratory distress in adults. , 1967, Lancet.
[121] P. Weinstein,et al. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C. , 1995, Journal of neurosurgery.
[122] B. Gesser,et al. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. , 1995, Journal of immunology.
[123] K. Kawasaki,et al. Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. , 1992, Kidney international.
[124] R. Bronson,et al. Lack of Evidence for Neutrophil Participation during Infarct Formation Following Focal Cerebral Ischemia in the Rat , 1996, Experimental Neurology.
[125] A. Cerami,et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. , 1993, Journal of immunology.